Last reviewed · How we verify
Physician-Directed OAC
Physician-Directed OAC is a software-based clinical decision support system that guides anticoagulation management in patients requiring oral anticoagulant therapy.
Physician-Directed OAC is a software-based clinical decision support system that guides anticoagulation management in patients requiring oral anticoagulant therapy. Used for Guidance for oral anticoagulant management in patients requiring anticoagulation therapy (e.g., atrial fibrillation, venous thromboembolism).
At a glance
| Generic name | Physician-Directed OAC |
|---|---|
| Sponsor | Biotronik, Inc. |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is not a pharmaceutical drug but rather a digital health tool developed by Biotronik for managing oral anticoagulant (OAC) therapy. It provides physicians with real-time guidance on anticoagulation decisions, dosing, and monitoring to optimize patient outcomes and reduce adverse events associated with anticoagulation therapy.
Approved indications
- Guidance for oral anticoagulant management in patients requiring anticoagulation therapy (e.g., atrial fibrillation, venous thromboembolism)
Common side effects
Key clinical trials
- Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Physician-Directed OAC CI brief — competitive landscape report
- Physician-Directed OAC updates RSS · CI watch RSS
- Biotronik, Inc. portfolio CI